Granted FDA Breakthrough designation, CardiAMP Cell Therapy uses a patient’s own bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure intended to increase ...
Ischemic heart disease, the leading cause of death in the United States, has long puzzled researchers. While high serum cholesterol levels are linked to cardiovascular risk, the role of dietary fat ...
Please provide your email address to receive an email when new articles are posted on . “We usually use [allopurinol] to treat gout and prevent gout flares because it lowers the uric acid levels and ...
In the Quinapril and Ischemic Events (QUIET) study, [24] the ACE inhibitor quinapril was administered to CAD patients who underwent percutaneous transluminal coronary angioplasty. A clinical benefit ...
Ischemic heart disease affects more than 18 million Americans, making it the leading cause of death nationwide. This condition occurs when coronary arteries become narrowed or blocked, restricting ...
Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with ...
The intervention being tested is the CardiAMP cell therapy system, which involves the use of autologous bone marrow mononuclear cells (ABM MNC). These cells are harvested from the patient’s bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback